$WCG (WellCare Health Plans, Inc.)

$WCG {{ '2016-08-26T10:48:02+0000' | timeago}} • Announcement

Managed care health plans provider $WCG said its subsidiary, WellCare of Kentucky, has named William Jones, most recently VP, Payment Integrity and Government Business Operations for Highmark, as State President, effective Aug. 25. Jones will report to Kelly Munson, SVP and Division President, WellCare Health Plans.

$UNH {{ '2018-01-17T18:35:18+0000' | timeago}} • Webcast

For 2018, health insurance provider UnitedHealth expects its profits between $16.7-17.3Bil. $UNH expects its premium revenues to reduce $400-500MM due to regulatory changes in Affordable Care Act. The company also plans to invest $200-300MM this year in artificial intelligence, data analytics etc. which would improve its engagement with customers.

$UNH {{ '2018-01-17T18:34:42+0000' | timeago}} • Webcast

UnitedHealth's 2017 medical care ratio increased 90 basis points to 82.1% vs. last year. Medical care ratio shows how much money is spent on healthcare from the premiums received by the health insurer. $UNH expects its 2018 medical care ratio to come around 81.5% plus or minus 50 basis points.

$UNH {{ '2018-01-17T18:34:08+0000' | timeago}} • Webcast

UnitedHealth's 4Q profits spiked to $3.62Bil whereas revenue was up 9% to $52.06Bil. $UNH's Health Insurance segment brings in more revenues, but Optum segment contributed more to its profits. Optum's profits were up 22% reaching $2.2Bil in 4Q. For 2017, the company reported a non-cash tax benefit of $1.22 per share due to tax reforms.

$UNH {{ '2018-01-17T13:48:18+0000' | timeago}} • Announcement

Largest US health insurer UnitedHealth's profits more than doubled in the fourth quarter to $3.61Bil due to tax benefits. $UNH also crossed $200Bil mark in revenues for FY17. The company now expects to save $1.7Bil in FY18 due to tax reforms. For 2018, the health insurer expects GAAP EPS between $11.65-11.95 and non-GAAP EPS between $12.30-12.60.

$AGN {{ '2018-01-17T13:14:16+0000' | timeago}} • Announcement

$AGN and $IRWD reached an agreement with Indian pharma company Sun Pharma to resolve a patent litigation for the generic version of constipation drug Linzess in the U.S. As per the agreement, Sun Pharma will be able to market the generic version of Linzess in the U.S. from Feb. 1, 2031. All the litigations related to Linzess were dismissed.

$HUM {{ '2018-01-16T20:57:20+0000' | timeago}} • Announcement

Healthcare company $HUM has appointed Luis Torres Olivera as President, Health and Well-being, for the Puerto Rico Market. Torres Olivera, who joined the company more than a decade ago, has overseen several key projects. He succeeds Earl Harper, who will be retiring at the end of February 2018.

$UNH {{ '2018-01-16T17:58:43+0000' | timeago}} • Infographic

$UNH UnitedHealth Group Incorporated Earnings AlphaGraphic: Q4 2017 Highlights

$MOH {{ '2018-01-11T21:46:24+0000' | timeago}} • Announcement

$MOH said COO Terry Bayer will be retiring in the next several weeks. The corporate COO role will no longer be a part of $MOH's organizational structure. This is consistent with the company's shift to a flatter organizational structure that will enable the CEO to be more directly involved with business and health plan operations.

$AGN {{ '2018-01-09T15:46:35+0000' | timeago}} • Announcement

$AGN, which announced its plan to give pink slips to 1,000 of its employees and cut down 400 open positions earlier this year, provided FY18 financial outlook. In 2018, Allergan plans to sell its remaining position of 10% stake in $TEVA through Forward Sale Agreements and/or open market sales.

$OMI {{ '2018-01-05T13:04:48+0000' | timeago}} • Announcement

Healthcare solutions firm $OMI plans to organize into two units, named Global Solutions and Global Products. The move is in connection with the acquisition and integration of Halyard Health’s Surgical & Infection Prevention business. Global Solutions will contain most of Owens’ legacy business, while Global Products will contain its S&IP business.

$AGN {{ '2017-12-26T12:22:55+0000' | timeago}} • Announcement

$AGN said that the Federal Circuit confirmed that a proposed generic version of Combigan eye drug from Sandoz, a unit of $NVS, did not infringe Allergan's two patents. The Federal Circuit also reversed the district court's decision that Sandoz's proposed generic product infringes Allergan's 3rd patent. Allergan plans to file for rehearing within 30 days.

$ANTM {{ '2017-12-21T19:37:12+0000' | timeago}} • Announcement

$ANTM completed the acquisition of Florida-based HealthSun, that provides managed healthcare plans. Financial terms of the deal remained undisclosed. With the addition of HealthSun, $ANTM's affiliated Medicare and Medicaid plans now serve more than 650,000 consumers in Florida. This deal is expected to be slightly accretive to earnings in 2018.

$AGN {{ '2017-12-21T14:38:43+0000' | timeago}} • Announcement

$AGN and its partner $PRTK announced that FDA accepted to review Seysara, an investigational drug for treating acne. Allergan, which has the U.S. rights of developing and marketing Seysara, expects FDA to take action on this in 2H18. Paratek retains the non-U.S. rights. In March 2017, Allergan announced positive results from Seysara Phase 3 trials.

$HUM {{ '2017-12-19T15:27:46+0000' | timeago}} • Announcement

$HUM signed a definitive agreement to acquire a 40% minority interest in the Kindred at Home Division of $KND for an estimated cash consideration of approximately $800MM. Humana does not anticipate a material impact to earnings in 2017 from this pending transaction.

$KND {{ '2017-12-19T13:44:51+0000' | timeago}} • Announcement

$KND's BoD approved a definitive agreement whereby it will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe and $HUM for about $4.1Bil in cash including the assumption or repayment of net debt. The transaction is expected to close during the summer of 2018.

$AGN {{ '2017-12-18T22:26:29+0000' | timeago}} • Announcement

Robert Stewart, COO of $AGN will resign from his role. He has been named as the CEO of the newly formed Amneal Pharmaceuticals, effective Jan. 25, 2018. Following Rob's departure, Wayne Swanton, SVP, Global Operations has been promoted as EVP, Global Operations of Allergan.

$AGN {{ '2017-12-18T22:14:14+0000' | timeago}} • Announcement

$AGN and its development partner Gedeon Richter Plc reported positive results from phase 3 study of cariprazine, which is used to treat the bipolar depression. Allergan plans to file the New Drug Application to the FDA in 2H18.

$IPXL {{ '2017-12-18T13:05:53+0000' | timeago}} • Announcement

Amneal Pharmaceuticals LLC and $IPXL said Robert Stewart will join Amneal as President, effective Jan. 25, 2018. Stewart most recently served as COO of $AGN. After completion of combination of Amneal and $IPXL, Stewart will become President and CEO of the combined company, to be named Amneal Pharmaceuticals Inc., and will become a BoD member.

$CI {{ '2017-12-15T12:13:02+0000' | timeago}} • Announcement

$CI acquired Brighter Inc., a platform that connects patients, providers, and payers. $CI expects Brighter’s digital health plan platform will help to accelerate and expand the consumer initiatives. The financial details of the deal remained undisclosed.

$HUM {{ '2017-12-14T14:23:30+0000' | timeago}} • Announcement

Health Insurance company $HUM has authorized a $3Bil share repurchase program, replacing a $2.25Bil program authorized by the company earlier. The new program will expire on December 31, 2020.

Recent Transcripts

UNH (UnitedHealth Group Incorporated)
Tuesday, January 16 2018 - 1:45pm
ENZ (Enzo Biochem Inc.)
Friday, December 8 2017 - 1:30pm
HQY (HealthEquity, Inc.)
Tuesday, December 5 2017 - 10:00pm
GTS (Triple-S Management Corporation)
Thursday, November 9 2017 - 2:00pm
CNCE (Concert Pharmaceuticals, Inc.)
Thursday, November 9 2017 - 1:30pm
VRML (Vermillion, Inc.)
Wednesday, November 8 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
CCXI (ChemoCentryx, Inc.)
Tuesday, November 7 2017 - 10:00pm
ATRS (Antares Pharma Inc.)
Tuesday, November 7 2017 - 1:30pm
PTLA (Portola Pharmaceuticals, Inc.)
Monday, November 6 2017 - 9:30pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
MGLN (Magellan Health, Inc.)
Wednesday, November 1 2017 - 2:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
AET (Aetna Inc.)
Tuesday, October 31 2017 - 12:30pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm
ANTM (Anthem, Inc.)
Wednesday, October 25 2017 - 12:30pm
CNC (Centene Corp.)
Tuesday, October 24 2017 - 12:30pm

AlphaGraphics you may like